| + |
MAPK3 | down-regulates
phosphorylation
|
BCL6 |
0.407 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-58489 |
Ser333 |
KGLVSPQsPQKSDCQ |
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-58493 |
Ser343 |
KSDCQPNsPTESCSS |
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Publications: |
2 |
Organism: |
Homo Sapiens |
| + |
MAPK1 | down-regulates
phosphorylation
|
BCL6 |
0.49 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-58481 |
Ser333 |
KGLVSPQsPQKSDCQ |
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-58485 |
Ser343 |
KSDCQPNsPTESCSS |
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Publications: |
2 |
Organism: |
Homo Sapiens |
| + |
NCOR1 | up-regulates activity
binding
|
BCL6 |
0.57 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-252239 |
|
|
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 10898795 |
The POZ domains of BCL-6 and several other POZ proteins interact with corepressors N-CoR and SMRT. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
Gbeta | down-regulates
phosphorylation
|
BCL6 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-270011 |
|
|
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BCOR | up-regulates activity
binding
|
BCL6 |
0.885 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-252235 |
|
|
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 10898795 |
In this study we have shown that BCoR interacts with BCL-6 and potentiates transcriptional repression by BCL-6 with striking specificity. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BCL6 | down-regulates quantity by repression
transcriptional regulation
|
LITAF |
0.354 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253758 |
|
|
Homo sapiens |
B-lymphoma Cell Line |
| pmid |
sentence |
| 23795761 |
BCL6 silencing increased LITAF expression, and chromatin immunoprecipitation and luciferase reporter assays demonstrated a direct transcriptional repression of LITAF by BCL6. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IL21 | up-regulates quantity by expression
transcriptional regulation
|
BCL6 |
0.4 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-196918 |
|
|
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 22486304 |
Interleukin-21 inhibits humoral response to an hiv dna vaccine by enhancing bcl-6 andpax-5expression. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
PAK1 | down-regulates activity
phosphorylation
|
BCL6 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253930 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 22723377 |
The transcriptional repressor B-cell lymphoma (BCL)-6 downregulates genes involved in cell-cycle progression and becomes inactivated following phosphorylation by the Rac1 GTPase-activated protein kinase PAK1. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
NCOR2 | up-regulates activity
binding
|
BCL6 |
0.632 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-252240 |
|
|
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 10898795 |
The POZ domains of BCL-6 and several other POZ proteins interact with corepressors N-CoR and SMRT. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
ERK1/2 | down-regulates
phosphorylation
|
BCL6 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-270140 |
|
|
Homo sapiens |
T-lymphocyte, Lymphoma Cell |
| pmid |
sentence |
| 9649500 |
Here we show that antigen receptor activation leads to bcl-6 phosphorylation by mitogen-activated protein kinase (mapk). Phosphorylation, in turn, targets bcl-6 for rapid degradation by the ubiquitin/proteasome pathway. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BCL6 | down-regulates quantity by repression
transcriptional regulation
|
SUMO1 |
0.306 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253929 |
|
|
Homo sapiens |
HT-29 Cell |
| pmid |
sentence |
| 22723377 |
QPCR analysis of the resulting gene expression levels identified three genes that were affected in opposite sense by the downregulation of either BCL-6 or STAT5, namely cyclin D2 (CCND2), cyclin-dependent kinase inhibitor p15INK4B (CDKN2B), and SUMO1 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
CTCF | down-regulates quantity by repression
transcriptional regulation
|
BCL6 |
0.279 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253824 |
|
|
Homo sapiens |
B-cell Lymphoma Cell |
| pmid |
sentence |
| 20733034 |
Inhibition of DNA methyltransferases decreased BCL6 mRNA abundance, suggesting a role for these methylated CpGs in positively regulating BCL6 transcription. The enhancer-blocking transcription factor CTCF bound to this intronic region in a methylation-sensitive manner. Depletion of CTCF by short hairpin RNA in neoplastic plasma cells that do not express BCL6 resulted in up-regulation of BCL6 transcription. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BCL6 | down-regulates quantity by repression
transcriptional regulation
|
CD80 |
0.41 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253931 |
|
|
Mus musculus |
B-lymphocyte |
| pmid |
sentence |
| 12860928 |
Upon CD40 signaling, transcription of the CD80 gene is induced by the nuclear factor (NF)-kappaB transcription factor. Our results show that BCL6 prevents CD40-induced expression of CD80 by binding its promoter region in vivo and suppressing its transcriptional activation by NF-kappaB. Consistent with a physiologic role for BCL6 in suppressing CD80, the expression of these two genes is mutually exclusive in B cells, and BCL6-defective mice show increased expression of CD80 in B cells. |
|
| Publications: |
1 |
Organism: |
Mus Musculus |
| + |
PRKD2 | down-regulates activity
phosphorylation
|
BCL6 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-279651 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 31980486 |
Prkd2 directly binds to Bcl6 and Prkd2-dependent phosphorylation of Bcl6 is necessary to constrain Bcl6 to the cytoplasm, thereby limiting TFH development. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
FBXO11 | down-regulates
binding
|
BCL6 |
0.491 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-177652 |
|
|
Homo sapiens |
Lymphoma Cell |
| pmid |
sentence |
| 22113614 |
Fbxo11 targets bcl6 for degradation |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
BCL6 | down-regulates quantity by repression
transcriptional regulation
|
FCER2 |
0.288 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-253928 |
|
|
Homo sapiens |
B-lymphocyte |
| pmid |
sentence |
| 11342629 |
In this study, we report that PRDI-BF1/Blimp1 can bind to the same functional element in the human CD23b promoter to which BCL-6 and IRF-4 had previously been shown to bind, and that, like BCL-6, Blimp1 can repress IRF-4-transactivating ability |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |